189
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Inhibitory effects of aqueous extracts from nardostachys Chinensis on α‐melanocyte stimulating hormone‐induced melanogenesis in B16F10 cells

, &
Pages 233-236 | Received 25 Sep 2006, Accepted 14 Nov 2006, Published online: 15 Nov 2010
 

Abstract

For the purpose of the development of skin‐whitening or therapeutic agents against hyperpigmentation, aqueous extract from Nardostachys chinensis (AENC) was evaluated for melanogenesis inhibitory activity in B16F10 melanoma cell. The treatment with AENC at the 0.2, 0.5 and 1.0 mg/ml level significantly inhibits the biosynthesis of melanin compared with untreated control. The tyrosinase activity also significantly decreased in AENC‐treated cells at the 0.2 and 0.5 mg/ml level and inhibitory effects were more efficient than commercial arbutin at 0.1 mg/ml. The Western analyses confirmed the significantly decreased expression of tyrosinase and tyrosinase‐related protein‐2 by AENC treatment. These results indicate that AENC may contribute to the inhibition of melanin biosynthesis through regulating the expression as well as activity of tyrosinase and AENC may be useful as a new candidate in the design of new skin‐whitening or therapeutic agents.

Notes

To whom correspondence should be addressed. Tel: +82–51 ‐850–8653; Fax: +82–51 ‐853–4036 E‐mail: [email protected]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.